Fundraising Fox

Outrun Therapeutics

Dundee, GB · 10 employees on LinkedIn · 2 known investors

Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases. Its lead programme targets an E3 ligase in hard-to-treat solid tumours.

BiotechDeep Tech

Founders & leadership

SV
Satpal VirdeeFounder

Investors · 2

M VenturesLos Angeles · $10.8M
MC Healthcare VenturesCambridge

Frequently asked questions

What does Outrun Therapeutics do?
Outrun Therapeutics is a preclinical biotech developing small molecule E3 ligase inhibitors to stabilise tumour suppressor proteins for treating cancer and other diseases. Its lead programme targets an E3 ligase in hard-to-treat solid tumours.
Who founded Outrun Therapeutics?
Outrun Therapeutics was founded by Satpal Virdee.
Who are Outrun Therapeutics's investors?
Outrun Therapeutics's investors include M Ventures, MC Healthcare Ventures.
Where is Outrun Therapeutics headquartered?
Outrun Therapeutics is headquartered in Dundee, GB.